Shenzhen Edge Medical-B (Stock Code: 02675) has notified the market that its board of directors will convene on 27 March 2026. Key items on the agenda include reviewing and approving the consolidated financial results for the year ended 31 December 2025, deciding on the release of the annual report, and deliberating on a potential final dividend.

The notice, dated 17 March 2026 and signed by Chairman and Executive Director Dr. Wang Jianchen, also confirms that any other routine corporate matters may be addressed during the session.

Edge Medical-B’s current board consists of nine members: three executive directors (Dr. Wang Jianchen, Dr. Gao Yuanqian and Ms. Wu Mengyuan), three non-executive directors (Mr. Sheng Li, Mr. Chen Gang and Mr. Qiu Xiang) and three independent non-executive directors (Mr. Yang Fan, Mr. Zhang Guoguang and Mr. Lau Ying Kit).